Final Report of the cosmetic ingredient review expert panel safety assessment of polymethyl methacrylate (PMMA), methyl methacrylate crosspolymer, and methyl methacrylate/glycol dimethacrylate crosspolymer

International Journal of Toxicology

Volumn 30, Issue 3, 2011, Pages

  Becker, Lillian C ^a   Bergfeld, Wilma F ^a   Belsito, Donald V ^a   Hill, Ronald A ^a   Klaassen, Curtis D ^a   Liebler, Daniel C ^a   Marks, James G ^a   Shank, Ronald C ^a   Slaga, Thomas J ^a   Snyder, Paul W ^a   Andersen, F Alan ^a  

^a NONE

Author keywords

cosmetics; methyl methacrylate glycol dimethacrylate crosspolymer; polymethyl methacrylate; safety

Indexed keywords

BIOMEDICAL AND DENTAL MATERIALS; BONE CEMENT; COSMETIC; FILLER; GLYCOL DIMETHACRYLATE; METHACRYLIC ACID METHYL ESTER; POLY(METHYL METHACRYLATE); POLYMER; UNCLASSIFIED DRUG; COPOLYMER; METHACRYLIC ACID;

ACUTE TOXICITY; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; COSMETIC INDUSTRY; EYE IRRITATION; FOOD AND DRUG ADMINISTRATION; HUMAN; LENS IMPLANT; MEDICAL INSTRUMENTATION; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; POLYMERIZATION; REVIEW; RISK ASSESSMENT; TRANSITION TEMPERATURE; VISCOSITY; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; INJECTABLE IMPLANT; MALE; MEDICAL DEVICE; PATCH TEST; PATIENT SAFETY;

ACRYLIC RESINS; ANIMALS; CONSUMER PRODUCT SAFETY; COSMETICS; HUMANS; MOLECULAR STRUCTURE; POLYMERS; POLYMETHYL METHACRYLATE; TOXICITY TESTS;

ANIMALIA;

EID: 79960679538     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581811407352     Document Type: Review

References (82)

1. Gottschalck TE, Bailey JE International Cosmetic Ingredient Dictionary and Handbook. 13 th ed Washington, DC: Personal Care Products Council (formerly the Cosmetic, Toiletry, and Fragrance Association ; 2010 :
2. Description of Polymethyl Methacrylate Used in Cosmetics. Washington, DC: Council ; 2009: 1-1.
3. Technical Data Sheet GanzPearl [pamphlet]. Somerset, NJ: Presperse, Incorporated ; 2010 :
4. Test [pamphlet]. Santa Barbara, CA: Particle Sizing Systems,Inc ; 2001 :
5. Presperse LLC Certificate of Analysis Ganzpearl GM-0600 [pamphlet]. Somerset, NJ: Presperse, LLC ; 2010 :
6. Specification Sheet [pamphlet]. Somerset, NJ: Presperse, Incorporated ; 2003 :
7. Schoon D. A brief overview of polymer powders used in artificial nail enhancement systems. :
8. Piacquadio D, Smith S, Anderson R. A comparison of commercially available polymethylmethacrylate-based soft tissue fillers. Dermatol Surg. 2008 ; 34 (supp 1). S48 - S52
9. U.S.Food and Drug Administration. General and plastic surgery devices panel of the Medical Devices Advisory Committee. U.S. Food and Drug Administration. 2003. www.fda.gov/ohms/dockets/ac/03/transcripts/3934t1- am%20serssion.doc.1-196. Accessed February 8, 2010.
10. Artecoll PMMA/Collagen Implant, P020012; Preclinical Review. :
11. Technical Data Sheet GanzPearl [pamphlet]. Somerset, NJ: Presperse Incorporated ; 2004 :
12. Sugaya H, Sakai Y. Polymethylmethacrylate: from polymer to dialyzer. Contrib Nephrol. 1999 ; 125: 1-8
13. Woodcock SE, Johnson WC, Chen Z. Collagen adsorption and structure on polymer surfaces observed by atomic force microscopy. J Colloid Interface Sci. 2005 ; 292 (1). 99-107 (Pubitemid 41531176)
14. Cholod MS, Parker H-Y. Poly(Methyl Methacrylate) (Overview). Polymeric Materials Encyclopedia. 1996 ;: 6385-6390
15. Cardre Inc. PMMA polymethyl methacrylate. www.cardre.com. Accessed April 15, 2010.
16. Ganz Chemical Co.LTD. GanzPearl: Spherical fine polymer beads. 1-6. Date Accessed 2-9-2010.
17. GanzPearl: Spherical fine polymer beads [pamphlet]. Minami Senba 1 Chome, Chuo-Ku, 542-0081 Osaka, Japan: Ganz Chemical Co, Ltd ; 2001: 13-27.
18. Gonçalves OH, Nogueira AL, Schilischting R, Coan T, Sanches AAF, Machado RAF. Methyl methacrylate suspension polymerization: Strategies on particle size distribution. 2nd Mercosur Congress on Chemical Engineering and 4th Mercosur Congress on Process Systems Engineering. 2005 ;:
19. U.S.Food and Drug Administration. Quality system regulation. 2009. pp.CFR 820.1-820.250. Code of Federal Regulations:
20. Standard analytical method (cosmetic GANZPEARL): Residual monomer (MMA, EGDM, and i-BMA) [pamphlet]. GANZ Chemical Co, Ltd ;
21. Nippo Y Japnese Stadard for Cosmetic Ingredients (JSCI). 2 nd ed Tokyo, Japan: Yakuji Nippo, Ltd ; 1985 :
22. Kaczmarczyk B, Morejko-Buz B, Stolarzewicz A. Investigation of infrared calibration methods for application to the study of methyl methacrylate polymerization. Fresenius J Anal Chem. 2001 ; 370 (7). 899-903
23. U.S.Food and Drug Administration. Class II Special Controls Guidance Document: Polymethylmathacrylate (PMMA) Bone Cement; Guidance for Industry and FDA. 7-17-2002. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/ucm072795.htm#bio. Accessed June 19, 2009.
24. Erckens RJ, March WF, Jongsma FH, et al. Noninvasive Raman spectroscopic identification of intraocular lens material in the living human eye. J Cataract Refract.Surg.. 2001 ; 27 (7). 1065-1070 (Pubitemid 32734156)
25. Vallittu PK, Miettinen V, Alakuijala P. Residual monomer content and its release into water from denture base materials. Dent.Mater.. 1995 ; 11 (6). 338-342
26. Polymethyl methacrylate-Summary of clincial study. 2001 ;: 1-1
27. VCRP total number of products in each product category, May 2010. 2010: 1-2
28. Concentration of Use Polymethyl Methacrylate, Methyl Methacrylate Crosspolymer, Methyl Methacrylate/Glycol Dimethacrylate Crosspolymer and Sodium Polymethacrylate. Washington DC: ; 2009: 1-3.
29. FDA database. Cosmetic Production Fomulation and Frequency of Use Data. Washington, DC: FDA ; 2009 :
30. Concentration of Use Polymethyl Methacrylate, Methyl Methacrylate Crosspolymer, Methyl Methacrylate/Glycol Dimethacrylate Crosspolymer and Sodium Polymethacrylate. Washington, DC: ; 2010: 1-3.
31. Health Canada. Use data for PMMA and related ingredients. 2010.
32. James AC, Stahlhofen W, Rudolf G, et al. Deposition of inhaled particles. Ann ICRP. 1994 ; 24 (1-3). 231-232
33. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005 ; 113 (7). 823-839 (Pubitemid 40984181)
34. Lehman-McKeeman LD Casarett and Doull's Toxicology: The Basic Science of Poisons. 7 th ed Klassen CD, ed. New York, NY: McGraw-Hill Companies, Inc ; 2008: 131-159.
35. Bower D.. 1999 CIR Expert Panel meeting in Washington, DC ; 1999 ; 1999..
36. Johnson MA. The influence of particle size. Spray Technol Market. 2004 ;: 24-27
37. Environmental Working Group. Browse products containing polymethyl methacrylate. http://www.cosmeticsdatabase.com/browse.php?containing= 705070&&showmore=products&atatime=500. Accessed February 15, 2010.
38. Use of polymethyl methacrylate in artificial nail products. :
39. Summary of Safety and Effectiveness Data: Tecnis Multifocal Intraocular Lens, Models ZM900 and ZMA00. :
40. Summary of Safety and Effectiveness Data: Premarket Approval Application (PMA) Number P980040. :
41. US Food and Drug Administration. 7-17-2002. http://www.fda.gov/ MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm072795.htm. Accessed June 19, 2009.
42. Polymethylmethacrylate (PMMA) bone cement. :
43. Artecoll PMMA/Collagen Implant, P020012; Preclincal Review. :
44. Summary of Safety and Effectiveness Data: ArteFill. :
45. Premarket Notification: Temporary Crown and Bridge Material. :
46. Brendolan A, Ronco C, Ghezzi PM, Scabardi M, La Greca G. Hydraulic and flow dynamic characteristics of PMMA dialyzers. Contrib Nephrol.. 1999 ; 125: 41-52
47. Di Filippo S, Manzoni C, Locatelli F. Efficiency parameters and treatment adequacy of hemodialysis and hemodiafiltration using polymethylmethacrylate membranes. Contrib Nephrol.. 1999 ; 125: 86-95
48. Sarnoff DS, Saini R, Gotkin RH. Comparison of filling agents for lip augmentation. Aesthet Surg J. 2008 ; 28 (5). 556-563
49. Dayan SH, Bassichis BA. Facial dermal fillers: selection of appropriate products and techniques. Aesthet Surg J.. 2008 ; 28 (3). 335-347 (Pubitemid 351672088)
50. Decoster TA, Bozorgnia S. Antibiotic beads. J Am Acad Orthop Surg. 2008 ; 16 (11). 674-678
51. Cheng YK, Weng HH, Yang JT, Lee MH, Wang TC, Chang CN. Factors affecting graft infection after cranioplasty. J Clin Neurosci. 2008 ; 15 (10). 1115-1119
52. Arevalo-Silva CA, Eavey RD, Cao Y, Vacanti M, Weng Y, Vacanti CA. Internal support of tissue-engineered cartilage. Arch Otolaryngol Head Neck Surg. 2000 ; 126 (12). 1448-1452
53. Tao S, Young C, Redenti S, Zhang Y, Klassen H, Desai T, Young MJ. Survival, migration and differentiation of retinal progenitor cells transplanted on micro-machined poly(methyl methacrylate) scaffolds to the subretinal space. Lab Chip. 2007 ; 7 (6). 695-701 (Pubitemid 46848695)
54. Al-Qattan MM. Late artecoll granulomas aggravated by pregnancy. Ann Plast Surg. 2007 ; 58 (5). 592 (Pubitemid 46659165)
55. Broder KW, Cohen SR. ArteFill: a permanent skin filler. Expert Rev Med Devices.. 2006 ; 3 (3). 281-289
56. Sanna V, Gavini E, Giunchedi P. Bilayer tablets based on poly (epsilon-caprolactone) and polymethylmethacrilates as controlled-release systems for ruminants. Pharm Dev Technol.. 2004 ; 9 (3). 321-328 (Pubitemid 39166284)
57. Nussbaum DA, Gailloud P, Murphy K. The chemistry of acrylic bone cements and implications for clinical use in image-guided therapy. J Vasc Interv Radiol.. 2004 ; 15 ((2 Pt 1)). 121-126 (Pubitemid 38248912)
58. Karademir K, Senkul T, Demir S, Erden D, Iseri C, Baykal K. A new testis prosthesis material: polymethylmethacrylate. Urol Int. 2004 ; 72 (1). 71-75 (Pubitemid 38134894)
59. Booth TM, Butson RJ, Clegg PD, Schramme MC, Smith RK. Treatment of sepsis in the small tarsal joints of 11 horses with gentamicin-impregnated polymethylmethacrylate beads. Vet Rec. 2001 ; 148 (12). 376-380 (Pubitemid 32267302)
60. Feretis C, Benakis P, Dimopoulos C, et al. Endoscopic implantation of Plexiglas (PMMA) microspheres for the treatment of GERD. Gastrointest Endosc.. 2001 ; 53 (4). 423-426 (Pubitemid 33586748)
61. Radhakrishnan VV, Saraswathy A, Rao VR, Rout D, Jayakrishnan A. Histopathological evaluation of polymethyl methacrylate as an embolic agent. Acta Neurochir (Wien).. 1992 ; 117 ((1-2)). 30-33
62. Batmanabane M, Malathi S, Ekandem GJ. Polymethyl methacrylate dissolved in chloroform as treatment for superficial digital injuries. Am J Surg. 1982 ; 144 (5). 527 (Pubitemid 13230341)
63. Ophthalmic Implants-Intraocular lenses-Part 5: Biocompatibility. :
64. Biological Evaluation of Medical Devices-Part 5: Tests for in Vitro Cytotoxicity. Switzerland: International Organization for Standards ; 2009: 1-42.
65. 510(k) Summary; Cobalt™ HV Bone Cement. Washington, DC: U.S. Food and Drug Administration ;
66. Biological Evaluation of Medical Devices-Part 1: Evaluation and Testing. Switzerland: International organization for Statndards ; 2003 :
67. Tecres Cemex System Bone Cement; Special 510(k) Summary of Safety and Effectiveness. Washington, DC: U.S. Food and Drug Administration ;
68. 510(k) Summary; SmarSet GHV Gentamicin Bone Cement. Washington, DC: U.S. Food and Drug Administration ;
69. 510(k) Summary; Spine-Fix Biomimetic Bone Cement. Washington, DC: U.S. Food and Drug Administration ;
70. 510(K) Summary DePuy Orthopaedics, Inc. Washington, DC: U.S. Food and Drug Administration ;
71. Bigatti MP, Lamberti L, Cannas M, Rossi E. Lack of sister-chromatid exchange induction by polymethyl methacrylate bone cement in human lymphocytes cultured in vitro. Mutat Res. 1989 ; 227 (1). 21-24 (Pubitemid 19222765)
72. PhillipsMK. Comment on Draft Report on PMMA 12-9-09. 2010.
73. Guidance for Industry and FDA Staff: Dental Composite Resin Devices-Premarket Notification [510(k)] Submissions. Washington, DC: FDA ; 2005: 1-10.
74. Oral Acute Toxicity Study of a Chemical Batch or Pharmaceutical Formulation in Male Mice: GANZ PEARL GM 0600. Not Clear. 1996: 1-6.
75. Determination of the Acute Ocular Irritation or Corrosion in Male Rabbits. Not Clear. 1996: 1-6.
76. Determination of the Acute Dermal Irritation or Corrosion in Male Rabbits. Not Clear. 1996: 1-7.
77. Summary of an HRIPT on a mascara containing 2.0% methyl methacrylate crosspolymer. 2008 :
78. Summary of an EpiOcular test on a mascara contianing 2.0% methyl methacrylate crosspolymer. 2008 :
79. Andersen FA. Amended final report on the safety assessment of ethyl methacrylate. Int J Toxicol. 2002 ; 21 ((suppl 1)). 63-79
80. Rustemeyer T, de Groot J, von Blomberg BME, Frosch PJ, Scheper RJ. Cross-reactivity patterns of contact-sensitizing methacrylates. Toxicol Appl Pharmacol. 1998 ; 148 (1). 83-90 (Pubitemid 28072779)
81. Kanazawa Y, Yoshida T, Kojima K. Structure-activity relationships in allergic contact dermatitis induced by methacrylates. Contact Dermatitis. 1999 ; 40 (1). 19-23
82. Betts CJ, Dearman RJ, Heylings JR, Kimber I, Basketer DA. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience. Contact Dermatitis. 2006 ; 55 (3). 140-147 (Pubitemid 44199270)